• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT IRELAND DIAGNOSTICS DIVISION LONGFORD ARCHITECT PROLACTIN

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT IRELAND DIAGNOSTICS DIVISION LONGFORD ARCHITECT PROLACTIN Back to Search Results
Model Number 7K76-25
Device Problem Low Test Results (2458)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 06/17/2020
Event Type  malfunction  
Manufacturer Narrative
Patient information: no further patient information was provided by the customer.An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.
 
Event Description
The customer observed a falsely depressed architect prolactin result for one patient.The following data was provided: (b)(6) 2020, sid (b)(6), initial result = 450 miu/l, repeat = 803 miu/l.The physician questioned the initial result since the patient had prolactin result of 800 miu/l at another laboratory.No impact to patient management was reported.
 
Manufacturer Narrative
The complaint investigation for the observed falsely depressed result included a search for similar complaints, and the review of complaint text, trending data, labeling, and device history records.Return testing was not completed as returns were not available.In-house accuracy testing of reagent lot 07137ui00 was completed.Trending review identify any trends for the complaint issue.In house accuracy testing of panels which mimic patient samples was completed using retained samples of the complaint lot.All specifications were met indicating that the lot is performing acceptably.A review of field data for lot 07137ui00 determined the patient median result for the lot is comparable with other lots in the field.Device history record review on lot 07137ui00 did not show any potential non-conformances, or deviations.Labeling was reviewed and found to adequately address the issue under review.Based on the investigation, no systemic issue or deficiency of the architect prolactin lot number 07137ui00 was identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCHITECT PROLACTIN
Type of Device
PROLACTIN
Manufacturer (Section D)
ABBOTT IRELAND DIAGNOSTICS DIVISION LONGFORD
lisnamuck
co. longford
longford NA
EI  NA
MDR Report Key10288795
MDR Text Key201870273
Report Number3005094123-2020-00151
Device Sequence Number1
Product Code CFT
UDI-Device Identifier00380740014865
UDI-Public00380740014865
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 08/14/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/17/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date07/23/2020
Device Model Number7K76-25
Device Catalogue Number07K76-25
Device Lot Number07137UI00
Was Device Available for Evaluation? No
Date Manufacturer Received07/31/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ARCHITECT I2000SR PROCESSING MODULE; ARCHITECT I2000SR PROCESSING MODULE; LIST 03M74-02, SERIAL (B)(6); LIST 03M74-02, SERIAL (B)(6)
-
-